We are live on ! Find out more
TS

Third Security Portfolio holdings

AUM $241M Turnover 0%
1-Year Est. Return 45.43%
This Fund
S&P 500
This Quarter Est. Return
-20.37%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
-$419M
Cap. Flow
+$26M
Cap. Flow %
2.23%
Top 10 Hldgs %
98.86%
Holding
15
New
–
Increased
2
Reduced
–
Closed
–
Avg Time Held
3.6 years
Top 10 Avg Time Held
2.9 years
Top 20 Avg Time Held
3.6 years

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$21.2M
2
FCSC
Fibrocell Science Inc.
FCSC
+$4.77M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.26%
2 Energy 4.92%
3 Consumer Staples 1.81%
4 Miscellaneous 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PGEN icon
1
Precigen
PGEN
$2.38B
$667M 57.24%
57,928,289
+1,423,236
+3% +$21.2M
2013 Q3
17 quarters
HALO icon
2
Halozyme
HALO
$13.9B
$356M 30.57%
17,592,771
– –
2013 Q2
18 quarters
TCRT icon
3
Alaunos Therapeutics
TCRT
$7.95M
$40.2M 3.45%
64,731
– –
2013 Q2
18 quarters
EPD icon
4
Enterprise Products Partners
EPD
$79.5B
$30.1M 2.58%
1,135,734
– –
2013 Q2
18 quarters
AQB icon
5
AquaBounty Technologies
AQB
$5.35M
$21.1M 1.81%
299,992
– –
2017 Q1
3 quarters
ET icon
6
Energy Transfer Partners
ET
$69.2B
$14.6M 1.25%
847,650
– –
2013 Q2
18 quarters
TOVX icon
7
Theriva Biologics
TOVX
$9.39M
$6.73M 0.58%
1,513
– –
2013 Q2
18 quarters
OCGN icon
8
Ocugen
OCGN
$267M
$5.52M 0.47%
44,843
– –
2014 Q4
12 quarters
FCSC
9
DELISTED
Fibrocell Science Inc.
FCSC
$5.29M 0.45%
1,653,483
+545,455
+49% +$4.77M
2013 Q2
18 quarters
TCP
10
DELISTED
TC Pipelines LP
TCP
$5.15M 0.44%
97,000
– –
2013 Q2
18 quarters
NS icon
11
DELISTED
NuStar Energy L.P.
NS
$4.35M 0.37%
145,200
– –
2013 Q2
18 quarters
OGEN icon
12
Oragenics
OGEN
$1.9M
$3.64M 0.31%
860
– –
2013 Q2
18 quarters
ETP
13
DELISTED
Energy Transfer Partners, L.P.
ETP
$3.17M 0.27%
176,828
– –
2017 Q2
2 quarters
PRPO icon
14
Precipio
PRPO
$39.2M
$1.63M 0.14%
4,530
– –
2017 Q2
2 quarters
TPST icon
15
Tempest Therapeutics
TPST
$10.1M
$523K 0.04%
128
– –
2013 Q4
16 quarters

Similar funds

KRC
Kehrs Ridge Capital Holmdel, New Jersey $260M AUM 0.46% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
FG
Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
UIA
UBP Investment Advisors Geneva, Switzerland $194M AUM 12.96% 1-Year Est. Return
GCM
Gabalex Capital Management New York $181M AUM 9.55% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return

Third Security's Q4 2017 Portfolio in Review

As of Q4 2017, Third Security held 15 positions worth $1.17B, down 26% from $1.59B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 0%. Third Security opened no new positions and made no exits, leaving the 15-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier, followed by Energy and Consumer Staples.

  • Third Security added most to Precigen in Q4 2017, an estimated $21.2M increase.
  • Third Security's ten largest holdings make up 99% of its $1.17B portfolio in Q4 2017.
  • Third Security opened 0 new positions and closed 0 in Q4 2017.
  • Third Security's portfolio value fell 26% quarter-over-quarter to $1.17B.

Based on Third Security's 13F filing for Q4 2017, filed 6 Feb 2018.